are compounded semaglutides going away 🚨 FDA Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these FDA ends semaglutide shortage, closing

muciniphila are outlined in Figure 1

A stronger immune system supports wound healing through better infection control and inflammatory resolution

Legislative authorization for the wildly popular program lapsed in late 2024, and although its direct impact had been blunted due to language permitting FDA to award PRVs until September 30, 2026 so long as the underlying products had received RPD designations before December 20, 2024, uncertainty over the programs fate was beginning to weigh on product developers and investors alike

Jason LA, Zinn ML, Zinn MA

Important Safety Reminder Regardless of which solution is used, neither bacteriostatic water nor sterile water should ever be injected on its own without medication

Most cover GLP-1 medication for type 2 diabetes, while coverage varies for weight loss and long-term weight management